Dafne Salas-Cuadros, MD

33 posts

Dafne Salas-Cuadros, MD banner
Dafne Salas-Cuadros, MD

Dafne Salas-Cuadros, MD

@_DafneSC

From 🇵🇪 in 🇺🇸 | Aspiring Internist | MD @UNSA_Oficial | MMSc in Immunology graduate @CayetanoHeredia | Certified @ECFMG_IMG

Delaware Katılım Eylül 2021
191 Takip Edilen82 Takipçiler
Dafne Salas-Cuadros, MD retweetledi
TidalHealth
TidalHealth@MyTidalHealth·
Today we officially welcome our new residents and fellows to TidalHealth! We're excited to have you on site and look forward to supporting you throughout your training journey. Wishing each of you a successful, rewarding year ahead!
TidalHealth tweet media
English
0
3
12
438
Dafne Salas-Cuadros, MD retweetledi
Yakup Ergün
Yakup Ergün@dr_yakupergun·
Epigenetics-targeted drugs: current paradigms and future challenges Many drugs are being developed in every field of oncology👇 nature.com/articles/s4139…
Yakup Ergün tweet media
English
0
66
183
18.4K
Dafne Salas-Cuadros, MD retweetledi
Paolo Tarantino
Paolo Tarantino@PTarantinoMD·
Happy Thanksgiving with the most impressive KM curve you’ll see today. PFS for first line nivo/ipi vs chemo in MSI-H mCRC. 🛻 Truck test: <0.001 nejm.org/doi/full/10.10…
Paolo Tarantino tweet media
English
13
84
397
39.4K
Dafne Salas-Cuadros, MD retweetledi
Yakup Ergün
Yakup Ergün@dr_yakupergun·
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer 2y PFS➡️72% vs 14% 💥When the right drug is given to the right patient at the right time, the survival curves can be as perfect as the one below👇 nejm.org/doi/full/10.10…
Yakup Ergün tweet media
English
3
48
166
15.4K
Dafne Salas-Cuadros, MD retweetledi
Steven Rattner
Steven Rattner@SteveRattner·
Over the last 50 years, 101 million infants around the world were saved by vaccines. Elevating anti-vaccine conspiracy theories would cost lives. @Morning_Joe
Steven Rattner tweet media
English
154
732
1.8K
67.2K
Dafne Salas-Cuadros, MD retweetledi
SAOM
SAOM@saom_oncologia·
📣 NUEVA FORMACIÓN: El próximo lunes 11 noviembre celebramos el Webinar #CáncerdePulmón MAP (Programa de Ayuda MDT) - Fase II, que cuenta con la colaboración de @AstraZenecaES. 💻 Sesión virtual 👉 Acceso a inscripción y programa: saom.es/congresos-curs… 🚀 ¡No te la pierdas!
SAOM tweet media
Español
0
1
2
477
Dafne Salas-Cuadros, MD retweetledi
Dr. Antonio Calles 🫁🚭
Dr. Antonio Calles 🫁🚭@Tony_Calles·
💥 The end of Pembro reign? Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: HARMONi-2 #WCLC24 #LCSM
Dr. Antonio Calles 🫁🚭 tweet mediaDr. Antonio Calles 🫁🚭 tweet mediaDr. Antonio Calles 🫁🚭 tweet mediaDr. Antonio Calles 🫁🚭 tweet media
English
7
70
230
31.8K
Dafne Salas-Cuadros, MD retweetledi
Therapeutic Advances in Medical Oncology
BLU-945, a next-gen EGFR TKI, shows promise against osimertinib-resistant NSCLC, shrinking tumors in preclinical models and in patients from the SYMPHONY trial. This could help fill treatment gaps for EGFR-mutant lung cancer. Read more: doi.org/10.1177/175883…
Therapeutic Advances in Medical Oncology tweet media
English
1
11
25
2.6K